Fed. Circ. Nixes Deal In Sun Pharma Eloxatin Suit
Sun Pharmaceutical Industries Inc. could be one step closer to selling a generic version of the colon cancer drug Eloxatin after convincing a federal appeals court to vacate and remand a...To view the full article, register now.
Already a subscriber? Click here to view full article